.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Glioblastoma multiforme (GBM) is a highly aggressive and heterogeneous brain cancer. Because of its complex nature, traditional treatments often fail to provide long-term survival. However, researchers are now focusing on targeted GBM therapy to improve clinical outcomes. By utilizing receptors overexpressed on the surface of tumor cells, scientists can deliver medication more precisely.
One major focus of this research involves receptors like interleukin-13 receptor alpha 2 (IL-13Rα2) and the transferrin receptor (TfR). These biomarkers allow for specific binding of drug-loaded carriers. Consequently, this approach reduces the exposure of healthy brain tissue to toxic chemotherapy. Furthermore, integrins and receptor tyrosine kinases (RTKs) serve as additional vital targets for these innovative platforms.
Modern nanotechnology plays a critical role in these advancements. Clinicians are exploring nanoparticles such as liposomes and gold nanostructures. These carriers are functionalized with specialized ligands like RGD peptides. These ligands act as a GPS, guiding drugs like temozolomide and gefitinib directly to the tumor. As a result, early-phase clinical trials are already showing promising safety and efficacy profiles.
Despite these successes, some challenges remain. For example, nanoparticle-associated cytotoxicity and off-target effects can limit clinical translation. Therefore, future research must prioritize the development of biodegradable and biocompatible nanomaterials. Additionally, exploring underexplored receptors like periostin (POSTN) could reveal new pathways for overcoming therapeutic resistance.
Commonly targeted receptors include IL-13Rα2, TfR, and integrins. These are highly expressed on tumor cells compared to normal brain tissue, allowing for selective drug delivery.
The main hurdles include crossing the blood-brain barrier effectively and minimizing nanoparticle-associated toxicity. Researchers are working on biocompatible designs to solve these issues.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Hadri SH et al. Exploring the potential of multiple receptors overexpressed on glioblastoma cells as biomarkers for the targeted therapy; a review. Ther Deliv. 2026 Jun 11. doi: 10.1080/20415990.2026.2682697. PMID: 42273826.
Rahman MA et al. Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities. Cancers (Basel). 2025 Feb 19;17(4):701. doi: 10.3390/cancers17040701. PMID: 40002294.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Glioblastoma multiforme remains a major clinical challenge. However, new research into targeted GBM therapy using specific receptors and nanoparticle-based delivery systems offers a path toward more effective and less toxic treatments. This review highlights recent progress and future opportunities.
3 months ago
A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today
A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today
A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday
The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today
